About this trial
The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
typical findings of PCI on colonoscopy; Line or pebble like sessile cysts are distributed around the colon with normal overlying mucosa
Disqualifiers
patients can not take Keishi-ka-shakuyaku-daio-to(TJ-134)
Trial design
Parallel
Treatments tested in this trial
Japanese traditional medicine group
DrugTJ-134 (7.5g/day) or lactomin (3g/day) is administered for 8 weeks.
Treatment groups
Trial outcomes
Primary outcomes
Change of computed tomography (CT) findings
Change of the intraluminal gas pockets in the colon on CT images before and after the administration of TJ-134
Secondary outcomes
Bloating and abdominal pain
Both bloating and abdominal pain are evaluated using visual analogue scale (VAS) score (0-100; 0, none).
Abdominal symptoms
Abdominal symptoms were evaluated on the Gastrointestinal Symptoms Rating Scale (GSRS) one a scale of 1 to5 (1 = none).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.